ArticleCancer immunology, immunotherapy : CII2017

The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.

Ana Colado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.